• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种含有工程化双脂磷壁酸II结合基序的羊毛硫抗生素对粪肠球菌显示出强效且选择性的抗菌活性。

An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium.

作者信息

Zhao Xinghong, Yin Zhongqiong, Breukink Eefjan, Moll Gert N, Kuipers Oscar P

机构信息

Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, The Netherlands.

Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, China.

出版信息

Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.02050-19.

DOI:10.1128/AAC.02050-19
PMID:32179527
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7269505/
Abstract

Lipid II is an essential precursor for bacterial cell wall biosynthesis and thereby an important target for various antibiotics. Several lanthionine-containing peptide antibiotics target lipid II with lanthionine-stabilized lipid II binding motifs. Here, we used the biosynthesis system of the lantibiotic nisin to synthesize a two-lipid II binding motifs-containing lantibiotic, termed TL19, which contains the N-terminal lipid II binding motif of nisin and the distinct C-terminal lipid II binding motif of one peptide of the two-component haloduracin (i.e., HalA1). Further characterization demonstrated that (i) TL19 exerts 64-fold stronger antimicrobial activity against than nisin(1-22), which has only one lipid II binding site, and (ii) both the N- and C-terminal domains are essential for the potent antimicrobial activity of TL19, as evidenced by mutagenesis of each single and the double domains. These results show the feasibility of a new approach to synthesize potent lantibiotics with two different lipid II binding motifs to treat specific antibiotic-resistant pathogens.

摘要

脂磷壁酸质II是细菌细胞壁生物合成的必需前体,因此是各种抗生素的重要作用靶点。几种含羊毛硫氨酸的肽类抗生素通过羊毛硫氨酸稳定的脂磷壁酸质II结合基序靶向脂磷壁酸质II。在此,我们利用乳链菌肽的生物合成系统合成了一种含两个脂磷壁酸质II结合基序的羊毛硫抗生素,称为TL19,它包含乳链菌肽的N端脂磷壁酸质II结合基序和双组分嗜碱菌素(即HalA1)中一个肽段独特的C端脂磷壁酸质II结合基序。进一步的表征表明:(i)TL19对[具体对象未给出]的抗菌活性比仅具有一个脂磷壁酸质II结合位点的乳链菌肽(1-22)强64倍;(ii)N端和C端结构域对TL19的强效抗菌活性均至关重要,对每个单结构域和双结构域进行诱变即可证明这一点。这些结果表明了一种新方法的可行性,即合成具有两种不同脂磷壁酸质II结合基序的强效羊毛硫抗生素来治疗特定的抗生素耐药病原体。

相似文献

1
An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium.一种含有工程化双脂磷壁酸II结合基序的羊毛硫抗生素对粪肠球菌显示出强效且选择性的抗菌活性。
Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.02050-19.
2
Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.A型类细菌素与十一异戊烯基磷酸聚糖结合的细胞包膜前体的相互作用。
Microb Drug Resist. 2012 Jun;18(3):261-70. doi: 10.1089/mdr.2011.0242. Epub 2012 Mar 20.
3
Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.羊毛硫抗生素植物乳杆菌素C基于脂质II的抗菌活性。
Appl Environ Microbiol. 2006 Apr;72(4):2809-14. doi: 10.1128/AEM.72.4.2809-2814.2006.
4
Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.从加里德明和表皮素作用机制研究中洞察羊毛硫抗生素的体内活性。
Antimicrob Agents Chemother. 2006 Apr;50(4):1449-57. doi: 10.1128/AAC.50.4.1449-1457.2006.
5
Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.提高基于乳链菌肽的类细菌素对革兰氏阴性病原体的抗菌活性。
Appl Environ Microbiol. 2018 May 31;84(12). doi: 10.1128/AEM.00052-18. Print 2018 Jun 15.
6
Molecular Recognition of Lipid II by Lantibiotics: Synthesis and Conformational Studies of Analogues of Nisin and Mutacin Rings A and B.脂Ⅱ的类细菌素分子识别:乳链菌肽和黏菌素环 A、B 类似物的合成与构象研究。
J Org Chem. 2019 Sep 20;84(18):11493-11512. doi: 10.1021/acs.joc.9b01253. Epub 2019 Aug 29.
7
Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.乳链菌肽与肽聚糖前体脂 II 的特异性结合结合了孔形成和细胞壁生物合成抑制,从而具有强大的抗生素活性。
J Biol Chem. 2001 Jan 19;276(3):1772-9. doi: 10.1074/jbc.M006770200. Epub 2000 Oct 18.
8
An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.针对脂质II的羊毛硫抗生素肽的另一种杀菌作用机制。
Science. 2006 Sep 15;313(5793):1636-7. doi: 10.1126/science.1129818.
9
Role of lipid II and membrane thickness in the mechanism of action of the lantibiotic bovicin HC5.类脂质 II 和膜厚度在羊毛硫抗生素 bovicin HC5 作用机制中的作用。
Antimicrob Agents Chemother. 2011 Nov;55(11):5284-93. doi: 10.1128/AAC.00638-11. Epub 2011 Aug 29.
10
A lesson in efficient killing from two-component lantibiotics.来自双组分羊毛硫抗生素的高效杀菌经验。
Mol Microbiol. 2006 Jul;61(2):271-3. doi: 10.1111/j.1365-2958.2006.05239.x. Epub 2006 Jun 12.

引用本文的文献

1
Promiscuity of lanthipeptide enzymes: new challenges and applications.羊毛硫肽酶的混杂性:新挑战与应用
World J Microbiol Biotechnol. 2025 Aug 6;41(8):298. doi: 10.1007/s11274-025-04505-5.
2
In Silico Identification of Potential Clovibactin-like Antibiotics Binding to Unique Cell Wall Precursors in Diverse Gram-Positive Bacterial Strains.通过计算机模拟鉴定与多种革兰氏阳性细菌菌株中独特细胞壁前体结合的潜在类氯缬菌素抗生素
Int J Mol Sci. 2025 Feb 18;26(4):1724. doi: 10.3390/ijms26041724.
3
Heterologous Expression and Characterization of Estercin A, a Class II Lanthipeptide Derived from CF016, with Antimicrobial Activity against Clinically Relevant Pathogens.

本文引用的文献

1
Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.提高基于乳链菌肽的类细菌素对革兰氏阴性病原体的抗菌活性。
Appl Environ Microbiol. 2018 May 31;84(12). doi: 10.1128/AEM.00052-18. Print 2018 Jun 15.
2
Insights into the Mechanism of Action of the Two-Peptide Lantibiotic Lacticin 3147.两肽类羊毛硫抗生素乳酸链球菌素 3147 的作用机制研究进展。
J Am Chem Soc. 2017 Dec 13;139(49):17803-17810. doi: 10.1021/jacs.7b04728. Epub 2017 Nov 22.
3
Synergistic effect of haloduracin and chloramphenicol against clinically important Gram-positive bacteria.
来自CF016的具有抗临床相关病原菌活性的II类羊毛硫肽A酯菌素A的异源表达与特性分析
J Nat Prod. 2025 Feb 28;88(2):262-273. doi: 10.1021/acs.jnatprod.4c00814. Epub 2025 Jan 15.
4
Biosynthesis of Antimicrobial Ornithine-Containing Lacticin 481 Analogues by Use of a Combinatorial Biosynthetic Pathway in .通过在……中使用组合生物合成途径生物合成含抗菌鸟氨酸的乳酸乳球菌素481类似物
ACS Synth Biol. 2024 Dec 20;13(12):4209-4217. doi: 10.1021/acssynbio.4c00650. Epub 2024 Dec 11.
5
Enhancing the Therapeutic Potential of Peptide Antibiotics Using Bacteriophage Mimicry Strategies.利用噬菌体模拟策略增强肽类抗生素的治疗潜力
Adv Sci (Weinh). 2025 Jan;12(3):e2411753. doi: 10.1002/advs.202411753. Epub 2024 Nov 25.
6
Discovery, Biosynthesis, and Characterization of Rodencin, a Two-Component Lanthipeptide, Harboring d-Amino Acids Introduced by the Unusual Dehydrogenase RodJ.发现、生物合成及 Rodencin 的特性鉴定,一种含有 d-氨基酸的双组份缩氨酸,由罕见的脱氢酶 RodJ 引入。
J Nat Prod. 2024 Oct 25;87(10):2344-2354. doi: 10.1021/acs.jnatprod.4c00170. Epub 2024 Sep 20.
7
Facile Halogenation of Antimicrobial Peptides As Demonstrated by Producing Bromotryptophan-Labeled Nisin Variants with Enhanced Antimicrobial Activity.通过生产具有增强抗菌活性的溴色氨酸标记乳链菌肽变体来展示抗菌肽的简便卤化。
J Nat Prod. 2024 Jun 28;87(6):1548-1555. doi: 10.1021/acs.jnatprod.4c00118. Epub 2024 Jun 18.
8
Brevicidine acts as an effective sensitizer of outer membrane-impermeable conventional antibiotics for treatment.短杆菌肽可作为一种有效的增敏剂,用于增强外膜不通透性的传统抗生素的治疗效果。
Front Microbiol. 2023 Dec 15;14:1304198. doi: 10.3389/fmicb.2023.1304198. eCollection 2023.
9
Engineering of Nisin as a Means for Improvement of Its Pharmacological Properties: A Review.乳链菌肽工程化:改善其药理特性的手段综述
Pharmaceuticals (Basel). 2023 Jul 26;16(8):1058. doi: 10.3390/ph16081058.
10
Beyond Conventional Meat Preservation: Saddling the Control of Bacteriocin and Lactic Acid Bacteria for Clean Label and Functional Meat Products.超越传统肉类保鲜:利用细菌素和乳酸菌控制技术打造清洁标签和功能性肉类产品。
Appl Biochem Biotechnol. 2024 Jun;196(6):3604-3635. doi: 10.1007/s12010-023-04680-x. Epub 2023 Aug 24.
卤代杜拉菌素与氯霉素对临床重要革兰氏阳性菌的协同作用。
Biotechnol Rep (Amst). 2016 Dec 27;13:37-41. doi: 10.1016/j.btre.2016.12.008. eCollection 2017 Mar.
4
Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid II.抗菌脂肽十三肽菌素A1选择性结合革兰氏阴性菌脂质II。
Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):11561-11566. doi: 10.1073/pnas.1608623113. Epub 2016 Sep 29.
5
Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials.利用类细菌素生物合成机器的多功能性来生产新型抗菌药物。
FEMS Microbiol Rev. 2017 Jan;41(1):5-18. doi: 10.1093/femsre/fuw034. Epub 2016 Sep 2.
6
Discovery, Production and Modification of Five Novel Lantibiotics Using the Promiscuous Nisin Modification Machinery.利用混杂的乳链菌肽修饰机制发现、生产及改造五种新型羊毛硫抗生素
ACS Synth Biol. 2016 Oct 21;5(10):1146-1154. doi: 10.1021/acssynbio.6b00033. Epub 2016 Jul 7.
7
Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria.脂质II靶向抗菌剂乳链菌肽、Lacticin 3147和万古霉素对革兰氏阳性菌的效力比较。
Probiotics Antimicrob Proteins. 2012 Jun;4(2):108-15. doi: 10.1007/s12602-012-9095-x.
8
Semisynthetic Lipopeptides Derived from Nisin Display Antibacterial Activity and Lipid II Binding on Par with That of the Parent Compound.半合成乳肽衍生物纳他霉素显示出与母体化合物相当的抗菌活性和与脂质 II 的结合能力。
J Am Chem Soc. 2015 Jul 29;137(29):9382-9. doi: 10.1021/jacs.5b04501. Epub 2015 Jul 14.
9
The length of a lantibiotic hinge region has profound influence on antimicrobial activity and host specificity.类细菌素铰链区的长度对其抗菌活性和宿主特异性有深远的影响。
Front Microbiol. 2015 Jan 29;6:11. doi: 10.3389/fmicb.2015.00011. eCollection 2015.
10
A new antibiotic kills pathogens without detectable resistance.一种新型抗生素能杀死病原体且未检测到耐药性。
Nature. 2015 Jan 22;517(7535):455-9. doi: 10.1038/nature14098. Epub 2015 Jan 7.